News

The trial was designed to evaluate safety, distribution and dosimetry of CardioPET as a PET tracer for myocardial imaging in healthy subjects and patients with coronary artery disease

The 111 study is a 12-week, Phase I, double-blind, parallel group, exploratory trial, where approximately 120 patients will be enrolled at around 30 clinical sites in the US.

The priority review designation means FDA is expected to make a decision on the NDA for the investigational compound within six months of the submission. If approved, Promacta

The companies will leverage Adept’s leadership in advanced image-guided robotic products and Prosurgics’s depth of experience in image-guided and navigated surgical robotic systems to create innovative products to

The transaction, which extends Gentiva’s home health operations to 37 states, has been funded from a combination of Gentiva’s existing cash balances and borrowings from its revolving credit

Under the terms of the agreement Neurobiological Technologies will exclusively license certain patent rights related to a naturally occurring protein that has been shown in animals to reverse

This randomized, double-blind, placebo and active-controlled, parallel-group study is designed to evaluate the compound’s safety and efficacy at three different doses in subjects with Stage I and Stage

As per the agreement, Pfizer will acquire the rights to SNX-5422, an oral Hsp90 inhibitor currently in Phase I trials for the potential treatment of solid tumors and

Under the terms of the collaboration, Raven will provide Emory with access to its prostate cancer stem cells. Raven will also provide Emory with a library of antibodies